26 research outputs found
Microstructural and mechanical characterisation of laser-welded high-carbon and stainless steel
The final publication is available at Springer via http://dx.doi.org/10.1007/s00170-015-7111-5Laser welding is becoming an important joining technique for welding of stainless steel to carbon steel and is extensively used across various sectors, including aerospace, transportation, power plants, electronics and other industries. However, welding of stainless steel to high-carbon steel is still at its early stage, predominantly due to the formation of hard brittle phases, which undermine the mechanical strength of the joint. This study reports a scientific investigation on controlling the brittle phase formation during laser dissimilar welding of high-carbon steel to stainless steel. Attempts have been made to tailor the microstructure and phase composition of the fusion zone through influencing the alloying composition and the cooling rate. Results show that the heat-affected zone (HAZ) within the high-carbon steel has significantly higher hardness than the weld area, which severely undermines the weld quality. To reduce the hardness of the HAZ, a new heat treatment strategy was proposed and evaluated using a finite element analysis-based numerical simulation model. A series of experiments has been performed to verify the developed thermo-metallurgical finite element analysis (FEA) model, and a qualitative agreement of predicted martensitic phase distribution is shown to exist
Serglycin as a potential biomarker for glioma : association of serglycin expression, extent of mast cell recruitment and glioblastoma progression
Serglycin is an intracellular proteoglycan with a unique ability to adopt highly divergent structures by glycosylation with variable types of glycosaminoglycans (GAGs) when expressed by different cell types. Serglycin is overexpressed in aggressive cancers suggesting its protumorigenic role. In this study, we explored the expression of serglycin in human glioma and its correlation with survival and immune cell infiltration. We demonstrate that serglycin is expressed in glioma and that increased expression predicts poor survival of patients. Analysis of serglycin expression in a large cohort of low-and high-grade human glioma samples reveals that its expression is grade dependent and is positively correlated with mast cell (MC) infiltration. Moreover, serglycin expression in patient-derived glioma cells is significantly increased upon MC co-culture. This is also accompanied by increased expression of CXCL12, CXCL10, as well as markers of cancer progression, including CD44, ZEB1 and vimentin. In conclusion, these findings indicate the importance of infiltrating MCs in glioma by modulating signaling cascades involving serglycin, CD44 and ZEB1. The present investigation reveals serglycin as a potential prognostic marker for glioma and demonstrates an association with the extent of MC recruitment and glioma progression, uncovering potential future therapeutic opportunities for patients
Remote Assessment of Cardiovascular Risk Factors and Cognition in Middle-Aged and Older Adults: Proof-of-Concept Study.
BackgroundAdults with cardiovascular disease risk factors (CVRFs) are also at increased risk of developing cognitive decline and dementia. However, it is often difficult to study the relationships between CVRFs and cognitive function because cognitive assessment typically requires time-consuming in-person neuropsychological evaluations that may not be feasible for real-world situations.ObjectiveWe conducted a proof-of-concept study to determine if the association between CVRFs and cognitive function could be detected using web-based, self-administered cognitive tasks and CVRF assessment.MethodsWe recruited 239 participants aged â„50 years (mean age 62.7 years, SD 8.8; 42.7% [n=102] female, 88.7% [n=212] White) who were enrolled in the Health eHeart Study, a web-based platform focused on cardiac disease. The participants self-reported CVRFs (hypertension, high cholesterol, diabetes, and atrial fibrillation) using web-based health surveys between August 2016 and July 2018. After an average of 3 years of follow-up, we remotely evaluated episodic memory, working memory, and executive function via the web-based Posit Science platform, BrainHQ. Raw data were normalized and averaged into 3 domain scores. We used linear regression models to examine the association between CVRFs and cognitive function.ResultsCVRF prevalence was 62.8% (n=150) for high cholesterol, 45.2% (n=108) for hypertension, 10.9% (n=26) for atrial fibrillation, and 7.5% (n=18) for diabetes. In multivariable models, atrial fibrillation was associated with worse working memory (ÎČ=-.51, 95% CI -0.91 to -0.11) and worse episodic memory (ÎČ=-.31, 95% CI -0.59 to -0.04); hypertension was associated with worse episodic memory (ÎČ=-.27, 95% CI -0.44 to -0.11). Diabetes and high cholesterol were not associated with cognitive performance.ConclusionsSelf-administered web-based tools can be used to detect both CVRFs and cognitive health. We observed that atrial fibrillation and hypertension were associated with worse cognitive function even in those in their 60s and 70s. The potential of mobile assessments to detect risk factors for cognitive aging merits further investigation
Perineal massage during labor: a systematic review and meta-analysis of randomized controlled trials
Recommended from our members
Targeted cognitive training improves auditory and verbal outcomes among treatment refractory schizophrenia patients mandated to residential care
Computerized targeted cognitive training (TCT) of auditory processing has been shown to improve verbal learning in several clinical trials of schizophrenia outpatients. Less is known, however, about the effectiveness of this promising intervention in more chronic, treatment-refractory patients who are treated in non-academic settings. This study aimed to determine whether TCT improves auditory processing, verbal learning, and clinical symptoms in SZ patients mandated to receive care at a locked residential rehabilitation center. Secondarily, potential factors that moderate TCT's effectiveness including age, symptom severity, antipsychotic medication load, and duration of illness were examined. Schizophrenia patients were randomized to treatment as usual (TAU; nâŻ=âŻ22) or TAU augmented with TCT (TAUâŻ+âŻTCT; nâŻ=âŻ24). Outcomes included a measure of auditory perception (Word-In-Noise test, WIN), verbal learning domain scores from the MATRICS Consensus Cognitive Battery (MCCB), and clinical symptoms (Scale for the Assessment of Positive Symptoms, SAPS; Scale for the Assessment of Negative Symptoms, SANS). TCT produced significant improvements in auditory perception (dâŻ=âŻ0.67) and verbal learning (dâŻ=âŻ0.65); exploratory analyses revealed a statistically significant reduction in auditory hallucinations (dâŻ=âŻ-0.64). TCT's effects were only weakly, and mostly non-significantly, moderated by age, clinical symptoms, medication, and illness duration. These findings indicate that even highly symptomatic, functionally disabled patients with chronic illness benefit from this emerging treatment. Ongoing studies will examine the predictive utility of neurophysiological biomarkers and other characteristics assessed at baseline